Skip to content

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07662603
Enrollment
40
Registered
2026-06-23
Start date
2026-05-06
Completion date
2026-09-06
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet Disease

Brief summary

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

Detailed description

Forty Behcet disease patients with pulmonary endoarterectomy will be assigned to group I or Group II. the patients will be adolescents, 20 patients in the group. Group I will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) Group II will act waitlist group.

Interventions

OTHERinspiratory muscle trianing

twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* adlescent patients * complain Behcet disease * after pulmonary endoarterectomy

Exclusion criteria

* chronci cardiac diseases * psychic disease * mental disease

Design outcomes

Primary

MeasureTime frameDescription
forced vital capacityit will be measured after 12 weeksit si a pulmaonry fucntion test

Secondary

MeasureTime frameDescription
forced expiratory volumeIt will be measured after 12 weeksit will be assessed in first second of expiration
ratio of force vital capcity to first-second-expiratory forced expiration volumeIt will be measured after 12 weeksit is a pulmoanry fucntion test
fatigue severity scaleIt will be measured after 12 weeksit will assess fatigue perception
child health questainanire parent form assessment of phsyical summaryit will be measured after 12 weeksit is an assessment of quality of life
child health questainanire parent form assessment of mental summaryIt will be measured after 12 weeksit is an assessment of quality of life
Ruffier indexIt will be measured after 12 weeksit an indiactor for cariorespiratory fitness
maxinmal inspiration pressureIt will be measured after 12 weeksit is an indicator for isnpiratory msucular stength
maxinmal expiration pressureIt will be measured after 12 weeksit is an indicator for expiratory msucular stength
six minute walk testIt will be measured after 12 weeksdistance covered during this test will be assessed

Countries

Egypt

Contacts

CONTACTAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
CONTACTali mohamed, lecturer
fatma1995@gmail.com01031321109
PRINCIPAL_INVESTIGATORAli MA Ismail, lecturer

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026